SCHEMBL26260010

SCHEMBL26260010

c1c[nH]c(-c2cccc3cccc(-c4ccc[nH]4)c23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.48
HSD17B10 Q99714 6/20 0.48
TSHR P16473 3/20 0.48
MAPK1 P28482 2/20 0.48
ATM Q13315 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
PARP1 P09874 3/20 0.45
AURKA O14965 1/20 0.44
KDR P35968 1/20 0.44
CES2 O00748 1/20 0.44
BCHE P06276 1/20 0.44
CES1 P23141 1/20 0.44
MCL1 Q07820 1/20 0.44
HPGD P15428 4/20 0.43
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
TP53 P04637 1/20 0.43
HIF1A Q16665 1/20 0.43
TYMS P04818 2/20 0.41
CYP3A4 P08684 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30360255 0.80 ALDH1A1 (0.47) ALDH1A1HSD17B10TSHRMAPK1ATM
SCHEMBL2289477 0.78 KDM4E (0.50) ALDH1A1HSD17B10TSHRPARP1AURKA
SCHEMBL26259996 0.78 AURKA (0.48) PARP1AURKAKDRCYP1B1CDK2
SCHEMBL13562857 0.78 ALDH1A1 (0.42) ALDH1A1HSD17B10TSHRMAPK1ATM
SCHEMBL15416821 0.78 KDR (0.47) ATMPARP1AURKAKDRCDK2
SCHEMBL29881143 0.74 ALDH1A1 (0.39) ALDH1A1HSD17B10TSHRMAPK1L3MBTL1
SCHEMBL28065244 0.74 HPRT1 (0.52) ALDH1A1HSD17B10TSHRMAPK1L3MBTL1
SCHEMBL27947964 0.74 AURKA (0.39) ALDH1A1HSD17B10TSHRMAPK1L3MBTL1
SCHEMBL1551082 0.73 AURKA (0.53) ATMPARP1AURKAKDRMCL1
SCHEMBL9864565 0.72 LMNA (0.52) ALDH1A1HSD17B10TSHRMAPK1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) 2023-09-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230287262-A1 PHOTON UPCONVERSION COMPOSITION, FILM, METHOD FOR CONVERTING VISIBLE LIGHT INTO ULTRAVIOLET LIGHT, AND COMPOUND NUDC, CCNL2, SPIN3 ALDH1A1 2125/4885HSD17B10 4034/4885TSHR 4840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.